Rachel K. King - Director at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
FULC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rachel K. King since 04 Feb 2025

Holdings reported by Rachel K. King for Fulcrum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 36,000 26 Jun 2025 Direct Common Stock

Transactions reported by Rachel K. King for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.